Celldex to Present at Upcoming Investor Conferences
Rhea-AI Summary
Celldex (NASDAQ:CLDX) announced management will participate in three upcoming investor conferences in February–March 2026, with live webcasts and 90-day replays available.
Events include Guggenheim Emerging Outlook: Biotech Summit on Feb 11 at 3:30 pm ET, TD Cowen Health Care on Mar 4 at 9:10 am ET, and Leerink Global Healthcare on Mar 10 at 3:40 pm ET.
Positive
- None.
Negative
- None.
News Market Reaction – CLDX
On the day this news was published, CLDX gained 4.42%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
HAMPTON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences:
- Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11 at 3:30 pm ET
- TD Cowen 46th Annual Health Care Conference on Wednesday, March 4 at 9:10 am ET
- Leerink Global Healthcare Conference on Tuesday, March 10 at 3:40 pm ET
Live webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event.
About Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.
Visit www.celldex.com.
Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com
Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com